Transesophageal Electrical Cardioversion for Atrial Fibrillation
The procedure you're asking about is transesophageal cardioversion (TEC), where a specialized electrode catheter or probe is inserted through the esophagus to deliver low-energy electrical shocks directly to the heart to restore normal rhythm in atrial fibrillation.
How the Procedure Works
Transesophageal cardioversion uses the esophagus's anatomical proximity to the left atrium to deliver electrical shocks more efficiently than traditional external cardioversion. Here's the algorithmic approach:
Procedural Steps
Probe Placement:
- A specialized electrode catheter is inserted through the nose or mouth into the esophagus, typically positioned 40-45 cm from the nasal orifice 1
- The cathode (negative electrode) sits in the esophagus adjacent to the left atrium
- An anode (positive electrode) may be placed in the right atrium via the internal jugular vein, or external chest electrodes are used 1
Energy Delivery:
- TEC requires dramatically lower energy than external cardioversion - typically 15-65 Joules compared to 100-360 Joules for transthoracic cardioversion 2, 3
- Shocks are synchronized with the QRS complex to prevent ventricular fibrillation
- A step-up protocol is used, starting at lower energies and increasing as needed 2
Sedation Requirements:
- Deep sedation is used (not general anesthesia) 2
- The procedure is generally well-tolerated, with most patients reporting minimal to mild discomfort 4
Clinical Efficacy
Success rates are excellent:
- 92.5% success rate for atrial flutter 5
- 84-96.7% success rate for atrial fibrillation 5, 4
- Can successfully cardiovert patients who failed external cardioversion 2
Combined TEE-Cardioversion Approach
A major advantage is simultaneous thrombus exclusion: The procedure can be combined with transesophageal echocardiography (TEE) using a cardioversion electrode sheath attached to the TEE probe 2. This allows:
- Real-time visualization to exclude left atrial thrombus
- Immediate cardioversion during the same sedation session
- Adherence to guideline recommendations for anticoagulation timing
Anticoagulation Context (Per Guidelines)
When using the TEE approach 6:
- If AF duration >48 hours or unknown: TEE can exclude thrombus, allowing immediate cardioversion without 3 weeks of prior anticoagulation
- If AF duration <48 hours: Early cardioversion can proceed without TEE (ESC Class IIa recommendation)
- Post-cardioversion: Anticoagulation for at least 4 weeks is still required regardless of method
Safety Profile
The procedure is remarkably safe:
- No cases of heart block or ventricular fibrillation reported in major studies 5
- Minimal esophageal injury risk - only 3 of 27 patients showed slight mucosal damage in one study, primarily in those with pre-existing gastroesophageal reflux disease 2
- Lower impedance (52.6 Ω) compared to transthoracic approach (63.1 Ω), explaining the lower energy requirements 3
Key Advantages Over External Cardioversion
- Lower energy requirements reduce myocardial damage risk
- Higher success rates, especially for refractory cases
- Can be performed without fluoroscopy outside the electrophysiology lab 1
- Better patient tolerance under sedation versus general anesthesia
- Simultaneous diagnostic capability when combined with TEE
Important Caveats
Relative contraindication: Avoid in patients with active gastroesophageal reflux disease due to increased risk of esophageal mucosal injury 2
Practical limitation: This technique requires specialized equipment and expertise, making it less widely available than standard external cardioversion. It's typically reserved for:
- Patients who failed external cardioversion
- Cases requiring TEE-guided approach for thrombus exclusion
- Patients where lower energy delivery is specifically advantageous
The procedure is not routinely performed as first-line therapy but represents an excellent option when external cardioversion fails or when combining cardioversion with TEE thrombus assessment is clinically indicated.